Arsanis, Inc. Report issue

For profit Phase 2
Founded: Vienna Austria (2010)
Status: Acquired by X4 Pharmaceuticals (2019)

Organization Overview

First Clinical Trial
2016
NCT02940626
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree